Georgia Prevention Institute, Department of Population Health Sciences, Medical College of Georgia, Augusta University, Augusta, GA.
Division of Nephrology, Department of Pediatrics, University of Washington, Seattle, WA.
Ethn Dis. 2018 Oct 18;28(4):511-516. doi: 10.18865/ed.28.4.511. eCollection 2018 Fall.
To test the hypothesis that Angiotensin II (Ang II) is a contributing factor to the response pattern in African Americans (AAs) who retain rather than excrete sodium during mental stress.
DESIGN/STUDY PARTICIPANTS: Double-blind, randomized, cross-over trial of 87 healthy AAs aged 18 to 50 years.
The study participants received either a placebo or irbesartan, (150 mg PO), an Ang II receptor antagonist, for seven days prior to stress testing. Urinary sodium excretion (UNaV) and systolic blood pressure (SBP) were collected prior to and throughout a mental stress protocol (rest and stress period).
A southeastern university.
Ang II, SBP, and sodium retention.
During the placebo condition, 62 participants showed the expected increase in UNaV (excreters) while 25 participants reduced UNaV during stress (retainers). Irbesartan retainers demonstrated a reversal in the direction of their natriuretic response, now increasing UNaV in response to stress (∆ UNaV of -.094 mmol/min with placebo vs .052 mmol/min on irbesartan; P<.001). In excreters, irbesartan reduced SBP levels during both rest (-2.36 mm Hg; P=.03) and stress (-4.59;P<.0001), and an even more pronounced reduction in SBP was demonstrated by retainers on treatment during both rest (-4.29 mm Hg; P=.03) and stress (-6.12; P<.001).
Ang II contributes to sodium retention in retainers. Furthermore, our findings indicate that suppression of Ang II has a beneficial effect on SBP during rest and stress in this population.
检验假设,即血管紧张素 II(Ang II)是导致非裔美国人(AAs)在心理应激时保留而不是排泄钠的反应模式的一个因素。
设计/研究参与者:对 18 至 50 岁的 87 名健康非裔美国人进行了双盲、随机、交叉试验。
在应激测试前,研究参与者接受安慰剂或厄贝沙坦(150mg PO),一种血管紧张素 II 受体拮抗剂,共 7 天。在心理应激方案(休息和应激期)之前和期间收集尿钠排泄量(UNaV)和收缩压(SBP)。
东南大学。
Ang II、SBP 和钠潴留。
在安慰剂条件下,62 名参与者表现出预期的 UNaV 增加(排泄者),而 25 名参与者在应激时减少 UNaV(保留者)。厄贝沙坦保留者的利钠反应方向发生逆转,现在对应激时增加 UNaV(安慰剂时为 -.094 mmol/min,厄贝沙坦时为.052 mmol/min;P<.001)。在排泄者中,厄贝沙坦在休息时(-2.36mmHg;P=.03)和应激时(-4.59mmHg;P<.0001)均降低 SBP 水平,保留者在治疗时的 SBP 降低更为明显,在休息时(-4.29mmHg;P=.03)和应激时(-6.12mmHg;P<.001)。
Ang II 促进保留者的钠潴留。此外,我们的发现表明,在该人群中,抑制 Ang II 对休息和应激时的 SBP 有有益影响。